The typical approach assigns peak revenues to the drugs protected period, applies a one-year transition period starting with the first generic entry, and then models a commoditized market at 15 to 25 percent of peak revenues
If levels shift significantly, discuss thyroid support options with your healthcare provider
Endocrinologists viewed their ideal patient as an individual with established cardiovascular disease or high cardiovascular risk, including those with diabetic kidney disease, who are already being treated with more than one oral medication (including either SGLT2is or GLP1-RAs) and an HbA1c level exceeding the established target
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (as Mounjaro) and for chronic weight management in adults with obesity or overweight with weight-related comorbidities (as Zepbound)
Safe travels, and may your journeys be filled with adventure, connection, and the peace of mind that comes from knowing your health needs are fully managed wherever you go